vTv Therapeutics Inc.
VTVT
$15.35
-$0.65-4.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.35% | 8.83% | 14.92% | -5.51% | -23.78% |
| Total Depreciation and Amortization | -15.56% | -1.11% | 0.00% | -2.17% | -1.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.19% | 54.87% | 42.76% | 99.63% | 77.40% |
| Change in Net Operating Assets | -775.92% | -223.76% | -228.63% | -45.92% | -73.15% |
| Cash from Operations | -11.34% | -32.63% | -1.51% | 19.33% | -5.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 21,071.43% |
| Total Debt Issued | -- | -- | -100.00% | -27.06% | -27.06% |
| Total Debt Repaid | 100.00% | 68.11% | 27.23% | 27.06% | 27.06% |
| Issuance of Common Stock | -95.11% | 338.89% | 229.37% | 131.15% | 87.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.11% | 338.50% | 228.14% | 131.15% | 87.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.29% | 1,118.66% | 569.41% | 725.51% | 405.27% |